Nyxoah SA current report, Q1 FY2022

Filing Overview

Nyxoah SA filed a Form 6-K on March 24, 2022, covering the month of March 2022. The filing reports that the company issued a press release announcing its financial and operating results for the year ended December 31, 2021.

Financial and Operating Metrics

The filing text provided does not include the attached press release or a clear value for revenue, profit or loss, cash flow, margins, debt, liquidity, operating expenses, or other financial metrics.

Changes Versus the Prior Comparable Period

The filing text does not provide comparative results or describe material changes versus the prior year.

Guidance, Outlook, Risks, and Unusual Items

The filing text does not provide guidance, outlook commentary, risk disclosures, contingencies, or details of unusual items. These matters may be discussed in Exhibit 99.1, the March 24, 2022 press release, which is referenced but not included in the provided text.

Important Facts to Verify

  • Review Exhibit 99.1 for the complete fiscal-year 2021 financial and operating results.
  • Verify revenue, net loss, cash burn, cash and equivalents, debt, and liquidity runway.
  • Check any reported changes in product sales, procedures, clinical programs, regulatory status, or geographic expansion.
  • Review management’s guidance, financing plans, contingencies, and principal risk factors.
  • The information was furnished under Form 6-K and is not deemed filed for purposes of Section 18 of the Exchange Act, except as otherwise specified.